Publicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (5)

2022

  1. First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial

    European Urology, Vol. 81, Núm. 3, pp. 266-271

2018

  1. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure presented]

    European Urology

  2. Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma

    New England Journal of Medicine, Vol. 378, Núm. 14, pp. 1277-1290

  3. The clinical activity of PD-1/PD-L1 inhibitors in metastatic non–clear cell renal cell carcinoma

    Cancer Immunology Research, Vol. 6, Núm. 7, pp. 758-765

2015

  1. Nivolumab versus everolimus in advanced renal-cell carcinoma

    New England Journal of Medicine, Vol. 373, Núm. 19, pp. 1803-1813